Sands Capital acquired 1.43 Million Repligen shares worth $246 Million. That's 0.72% of their equity portfolio (34th largest holding). The investor owns 2.58% of the outstanding Repligen stock. Sands Capital started to build up the position in Repligen in Q3 2022 and continued to invest until Q4 2022. Since then they sold 349 Thousand shares. The investor's estimated purchase price is $299 Million, resulting in a loss of 18%.
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” third-quarter 2023 investor letter. A copy of the same can b...
Insider Monkey, 6 months agohttps://www.investing.com/news/pro/repligen-corp-receives-investment-bank-analyst-rating-update-3120648
Investing.com, 11 months agoPulled from Benzinga Pro data, Repligen (NASDAQ: RGEN ) posted Q1 earnings of $28.83 million, an increase from Q4 of 40.84%. Sales dropped to $182.66 million...
Benzinga, about 1 year agohttps://www.investing.com/news/pro/rbc-capital-starts-repligen-at-sector-perform-432SI-2958584
Investing.com, over 1 year ago